FindTrial
Sign In

Assessing the Efficacy and safety of Ultrasound-Guided Intrathecal Injections of Nusinersen for Spinal Muscular Atrophy with Complex Spinal Deformities: A Retrospective Analysis

Ultrasound Guided Intrathecal Injections of Nusinersen for Patients with Spinal Muscular Atrophy Complicated by Complex Spinal Deformities: A Retrospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075122
Enrollment
Unknown
Registered
2023-08-25
Start date
2023-08-25
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal muscular atrophy

Interventions

SMA patients:NA

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: From January 1, 2022, to August 25, 2023, patients diagnosed with adult or adolescent types SMA and underwent ultrasound-guided intrathecal injection of nusinersen at our hospital."

Exclusion criteria

Exclusion criteria: SMA patients received intrathecal Nusinersen injection guided by a technique other than ultrasound.

Design outcomes

Primary

MeasureTime frame
success rate of lumbar puncture;—

Secondary

MeasureTime frame
time duration of lumbar puncture;—

Countries

China

Contacts

Public ContactMin Zhang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

371937252@qq.com+86 27 8366 3173

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026